Patent · US Active

Substituted pyrido[3,4-b]pyrazines as Syk inhibitors

US10052330B2 · kind B2 · utility

1Cited by

0References

34Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Wei-Guo Su · Shanghai, CN
Wei Deng · Shanghai, CN
Jianguo Ji · Shanghai, CN

Key dates

Filing date	Jul 15, 2016
Grant date	Aug 21, 2018
Priority date	—
Expiry date	Jul 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.